mike
12-21-2004, 10:02 AM
Looks like Canada is moving ahead of the U.S.again with the approval of Sativex for Neuropathic pain. Although the specific approval is for pain related to MS, GW Pharmaceuticals is presently running trials for this drug for SCI related pain as well.
http://www.gwpharm.com/news_press_releases.asp?id=/gwp/pressreleases/currentpress/2004-12-21/
mike
http://www.gwpharm.com/news_press_releases.asp?id=/gwp/pressreleases/currentpress/2004-12-21/
mike